Frankfurt - Delayed Quote EUR

Kobayashi Pharmaceutical Co., Ltd. (KOY.F)

30.00
-0.20
(-0.66%)
As of 8:02:10 AM GMT+2. Market Open.
Loading Chart for KOY.F
  • Previous Close 30.20
  • Open 30.00
  • Bid 30.00 x 30000
  • Ask 32.00 x 30000
  • Day's Range 30.00 - 30.00
  • 52 Week Range 29.60 - 39.20
  • Volume 25
  • Avg. Volume 0
  • Market Cap (intraday) 2.302B
  • Beta (5Y Monthly) 0.47
  • PE Ratio (TTM) 34.09
  • EPS (TTM) 0.88
  • Earnings Date Aug 6, 2025 - Aug 11, 2025
  • Forward Dividend & Yield 0.66 (2.20%)
  • Ex-Dividend Date Jun 27, 2025
  • 1y Target Est --

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of OTC pharmaceuticals, guasi-drugs, deodorizing air fresheners, and sanitary products in Japan and internationally. The company offers Ammeltz, an anti-inflammatory pain relief medicine; Dent, an effervescent denture cleaning agent; Ekitai Bluelet Okudake, a toilet bowl cleaner; Naicitol, a Chinese medicine; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet; and deodorizing air freshener, lens cleaner, cooling gel sheets, and oral hygiene products. It also manufactures and sells pharmaceuticals, cosmetics, and health foods; and manufactures and sells synthetic resin products; markets nutritional supplements and skin care products through mail orders; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers. In addition, the company engages in transportation, real estate management, and advertising planning and production businesses; manufacture of sanitary and paper products; and asset management. Kobayashi Pharmaceutical Co., Ltd. was founded in 1886 and is headquartered in Osaka, Japan.

www.kobayashi.co.jp

3,615

Full Time Employees

December 31

Fiscal Year Ends

Recent News: KOY.F

View More

Performance Overview: KOY.F

Trailing total returns as of 5/22/2025, which may include dividends or other distributions. Benchmark is Nikkei 225 (^N225) .

YTD Return

KOY.F
18.48%
Nikkei 225 (^N225)
7.29%

1-Year Return

KOY.F
335.96%
Nikkei 225 (^N225)
4.22%

3-Year Return

KOY.F
65,352.75%
Nikkei 225 (^N225)
38.32%

5-Year Return

KOY.F
1,020,909.40%
Nikkei 225 (^N225)
81.41%

Compare To: KOY.F

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: KOY.F

View More

Valuation Measures

Annual
As of 5/21/2025
  • Market Cap

    2.32B

  • Enterprise Value

    1.91B

  • Trailing P/E

    34.14

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.26

  • Price/Book (mrq)

    1.77

  • Enterprise Value/Revenue

    1.92

  • Enterprise Value/EBITDA

    22.07

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.63%

  • Return on Assets (ttm)

    5.41%

  • Return on Equity (ttm)

    5.20%

  • Revenue (ttm)

    161.72B

  • Net Income Avi to Common (ttm)

    10.71B

  • Diluted EPS (ttm)

    0.88

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    67.28B

  • Total Debt/Equity (mrq)

    0.38%

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: KOY.F

View More

Company Insights: KOY.F

Research Reports: KOY.F

View More

People Also Watch